Transient expression of antinuclear RNP-A antibodies in patients with acute COVID-19 infection

Transient expression of antinuclear RNP-A antibodies in patients with acute COVID-19 infection

Introduction: Viral infections have been implicated in the initiation of the autoimmune diseases. Recent reports suggest that a proportion of patients with COVID-19 develop severe disease with multiple organ injuries. We evaluated the relationship between COVID-19 severity, prevalence and persistenc...

Full description

Bibliographic Details
Main Authors:	Shuxia Zhou, Ravi Kaul, Kara L. Lynch, Alan H.B. Wu, Roger P. Walker
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	Journal of Translational Autoimmunity
Subjects:	SARS-CoV-2 COVID-19 Antinuclear antibody RNP-A Neutralizing antibody Nucleocapsid protein
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589909022000363

Similar Items

Detection of SARS-CoV-2 Nucleocapsid, Spike, and Neutralizing Antibodies in Vaccinated Japanese
by: Rie Midorikawa, et al.
Published: (2022-05-01)

Inappropriate use of commercial Antinuclear Antibody Testing in a community-based US hospital: a retrospective study
by: Abdul S. Mohammed, et al.
Published: (2016-09-01)

Can Antinuclear Antibodies Have a Pathogenic Role in Systemic Sclerosis?
by: Aurélien Chepy, et al.
Published: (2022-06-01)

Antinuclear antibodies in postinfectious smell loss - a pilot study
by: U. Walliczek-Dworschak, et al.
Published: (2019-01-01)

Comparative performance of COVID-19 serology testing
by: Nam K. Tran, et al.
Published: (2022-08-01)

Antinuclear Antibodies: A demographic profile from a Tertiary Healthcare Centre of Delhi
by: Krishna Sarkar, et al.
Published: (2023-07-01)

Antinuclear antibodies in systemic sclerosis associated with increased risk of malignancy
by: Anna Stochmal, et al.
Published: (2018-11-01)

Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals
by: Etienne Brochot, et al.
Published: (2020-10-01)

Russian-language adaptation of the international nomenclature of International Consensus on Antinuclear Antibody (ANA) Patterns (ICAP)
by: O. Yu. Tkachenko, et al.
Published: (2021-01-01)

Clinical diagnoses associated with a positive antinuclear antibody test in patients with and without autoimmune disease
by: Jacy T. Zanussi, et al.
Published: (2023-08-01)

Recombinant COVID-19 vaccine based on recombinant RBD/Nucleoprotein and saponin adjuvant induces long-lasting neutralizing antibodies and cellular immunity
by: Amir Ghaemi, et al.
Published: (2022-09-01)

Could Antinuclear Antibody Positivity Be a Factor Affecting Treatment Response in Immune Thrombocytopenia Patients on Eltrombopag?
by: Mehmet Baysal, et al.
Published: (2022-02-01)

The Prevalence of Antinuclear Antibodies in the General Population of China: A Cross-Sectional Study
by: Ya-Ping Guo, BS, et al.
Published: (2014-12-01)

Prevalence of antinuclear antibody in patients with multiple sclerosis: a case-control study
by: Hind Alnajashi, et al.
Published: (2021-02-01)

High Prevalence of Undocumented SARS-CoV-2 Infections in the Pediatric Population of the Tyrolean District of Schwaz
by: Teresa Harthaller, et al.
Published: (2022-10-01)

Demystifying antinuclear antibodies and other serological tests in dermatology practice
by: Anupam Berwal, et al.
Published: (2019-01-01)

Hypertrophic Pulmonary Osteoarthropathy with Positive Antinuclear Antibodies: Case Report
by: C. Cruz, et al.
Published: (2012-06-01)

Antinuclear antibody-negative systemic lupus erythematosus
by: Krithiga Muralidharan, et al.
Published: (2023-01-01)

Modulation of Serum Antinuclear Antibody Levels by Levamisole Treatment in Patients With Oral Lichen Planus
by: Hung-Pin Lin, et al.
Published: (2011-05-01)

Pre-treatment antinuclear antibody positivity, therapeutic efficacy and persistence of biologics in rheumatoid arthritis
by: Codreanu Cătălin, et al.
Published: (2016-06-01)

Seroprevalence of antinuclear antibodies, antibrucella antibodies, and hepatitis B surface antigen in women with recurrent abortion
by: Nabaz Fisal Shakir Agha
Published: (2020-01-01)

SARS-CoV-2 Antibody Isotypes in Systemic Lupus Erythematosus Patients Prior to Vaccination: Associations With Disease Activity, Antinuclear Antibodies, and Immunomodulatory Drugs During the First Year of the Pandemic
by: Johanna Sjöwall, et al.
Published: (2021-08-01)

Fator antinúcleo na dermatologia Antinuclear factor in dermatology
by: Artur Antônio Duarte
Published: (2005-08-01)

Immunofluorescence pattern of antinuclear antibody and its association with autoantibody profile in systemic lupus erythematosus
by: Sadia Sharmin, et al.
Published: (2016-08-01)

Report of the First International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns (ICAP) 2014-2015
by: Edward K.L. Chan, et al.
Published: (2015-08-01)

Clinical research on progress of antinuclear antibody in rheumatoid arthritis
by: LI Yuan, ZHANG Le, YIN Hanlin, ZHENG Bing, LÜ Liangjing
Published: (2023-12-01)

Fully automated chemiluminescence microarray immunoassay for detection of antinuclear antibodies in systemic autoimmune rheumatic diseases
by: Yuan Dandan, et al.
Published: (2024-04-01)

SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History
by: Steven J. Drews, et al.
Published: (2022-02-01)

Antimitochindrial and antinuclear antibodies in primary biliary cholangitis
by: Dana Saipiyeva, et al.
Published: (2019-06-01)

Serum antinuclear antibodies associate with worse prognosis in AQP4‐positive neuromyelitis optica spectrum disorder
by: Rong Fan, et al.
Published: (2021-01-01)

Neutralizing and enhancing antibodies against SARS-CoV-2
by: Yafei Liu, et al.
Published: (2022-12-01)

Properties of Uncommon Indirect Immunofluorescence Staining Patterns Determined during Antinuclear Antibody Detection on HEp-2 Cells
by: Nada Tomić Sremec, et al.
Published: (2021-08-01)

Quantification of Antifibrillarin (anti-U3 RNP) Antibodies: A New Insight for Patients with Systemic Sclerosis
by: Audrey Benyamine, et al.
Published: (2021-06-01)

Association between serum antinuclear antibody and rheumatoid arthritis
by: Fang Liu, et al.
Published: (2024-04-01)

Antinuclear antibody and rheumatoid factor positivity in temporomandibular disorders
by: Ji Rak Kim, et al.
Published: (2018-11-01)

The effect of biological agents on antinuclear antibody status in patients with psoriasis: A single-center study
by: Ömer Kutlu, et al.
Published: (2020-01-01)

Utilización y valor predictivo de la determinación de anticuerpos antinucleares en un Hospital de Referencia Nacional de Salud Use and predictive value of the determination of antinuclear antibodies in a national health reference hospital
by: Elena Kokuina, et al.
Published: (2006-09-01)

Longitudinal clinico-serological analysis of anti-nucleocapsid and anti-receptor binding domain of spike protein antibodies against SARS-CoV-2
by: Gururaj Rao Deshpande, et al.
Published: (2021-11-01)

Antinuclear Autoantibodies in Health: Autoimmunity Is Not a Synonym of Autoimmune Disease
by: Irina A. Pashnina, et al.
Published: (2021-02-01)

Comprehensive Exploration of Antinuclear Antibodies (ANAs): Unveiling Clinical Significance, Associations with Cancer, and the Nuances of Differential Diagnosis in Positive ANA Patients
by: Krasimir Kraev, et al.
Published: (2024-02-01)